|
WO2017048038A1
|
|
Combination vaccine composition for multiple-dosage
|
|
TW201707707A
|
|
Preparation comprising indole compound and process for preparing the same
|
|
WO2016108569A1
|
|
Method for producing tnfr-fc fusion protein containing target content of impurities
|
|
CN107567443A
|
|
Biaryl derivatives as GPR120 activators
|
|
KR20160043519A
|
|
Prevention and treatment of vascular complications by using gemigliptin and active metabolites thereof
|
|
MX2016009848A
|
|
Method for controlling galactosylation of recombinant protein through optimization of culture medium.
|
|
KR20150088753A
|
|
Composition for preventing or treating acute lung injury and acute respiratory distress syndrome
|
|
WO2015108328A1
|
|
Novel ntrk1 fusion gene as colorectal cancer marker and use thereof
|
|
KR20160081699A
|
|
A method for controlling glycosylation of recombinant glycoprotein
|
|
KR20150085459A
|
|
Novel NTRK1 fusion gene as colon cancer marker and the uses thereof
|
|
WO2015053576A1
|
|
Method for preparation of 3-alkylthio-2-bromopyridine
|
|
WO2015026170A1
|
|
Indole compound as inhibitor of necrosis
|
|
WO2015026172A1
|
|
Indole amide compound as inhibitor of necrosis
|
|
KR20150125402A
|
|
A protein secretory factor with a high secretory efficiency and a expression vector comprising the same
|
|
EP2977048A1
|
|
Complex preparation including valsartan and rosuvastatin calcium and manufacturing method therefor
|
|
KR20140059138A
|
|
Thioaryl derivatives as gpr120 agonists
|
|
TW201416095A
|
|
Combination drug comprising gemigliptin and metformin, and method for the preparation thereof
|
|
KR20140117244A
|
|
A pharmaceutical composition for suppressing immune response via promoting differentiation and proliferation of regulatory T cell
|
|
TN2013000212A1
|
|
Complex formulation comprising lercanidipine hydrochloride and valsartan and mathod for the preparation therof
|
|
KR20140000627A
|
|
Medicinal herb composition for improvement, treatment and prevention of gastrointestinal motility disorders
|
